Homeopathic medicines for treatment of erectile problems
- Conditions
- Health Condition 1: N521- Erectile dysfunction due to diseases classified elsewhere
- Registration Number
- CTRI/2023/03/050318
- Lead Sponsor
- D N De Homoeopathic Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients suffering from ED (ICD10-Code N52).
2. Male Patients aged between 18 and 65 years.
3. Literate patients; ability to read English and/or Bengali and/or Hindi. Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires.
4. Providing written informed consent voluntarily.
1. Vulnerable population - unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, and mentally incompetent people.
2. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled diabetes or life-threatening illness affecting the quality of life or any organ failure.
3. Patient with a habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence.
4. History of significant injury to the lower back or any other spinal injury followed by erectile dysfunction
5. Self-reported immune-compromised state.
6. Already undergoing homoeopathic treatment for chronic disease or any other mode of treatment for ED within the last 6 months.
7. Simultaneous participation in any other clinical trials.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method International Index of Erectile Function (IIEF)Timepoint: At baseline, and every month, up to 3 months of intervention
- Secondary Outcome Measures
Name Time Method Male Sexual Health QuestionnaireTimepoint: At baseline, and every month, up to 3 months of intervention;Measure Yourself Medical Outcome Profile v2 (MYMOP-2) questionnaireTimepoint: At baseline, and every month, up to 3 months of intervention